+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Blood Banking and NAT Screening Market 2019-2023: Supplier Shares by Country, Instrumentation Review and Strategic Profiles of Leading Suppliers

  • ID: 4143727
  • Report
  • June 2019
  • Region: Global
  • 111 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diagast
  • Grifols
  • LabCorp
  • Quidel
  • MORE
This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.

The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher
Note: Product cover images may vary from those shown
Adroll
adroll